Patient characteristics and the distributions of marrow fibrosis and dysplasia. (A) Patient characteristics of the study cohort. (B) Pie chart showing the presence of dysplasia in assessed BM samples in any hematologic lineage. (C) Pie chart of the presence of BM fibrosis. (D) Cumulative incidence of MR4 based on BM fibrosis. (E) Cumulative incidence of MR4.5 based on BM fibrosis. ICC, International Consensus Classification.